The proposed bill, known as the Pharmacists Test-and-Treat Authority Act, aims to enhance public health by authorizing licensed pharmacists to independently test for and initiate treatment of certain conditions. The bill establishes a new chapter in the General Laws that outlines the authority of pharmacists to provide test-and-treat services, which includes ordering, performing, and interpreting CLIA-waived tests, initiating, dispensing, administering, or prescribing medications, and providing patient counseling and education.

The Board of Pharmacy, in consultation with the Department of Health, will develop statewide protocols for the conditions that pharmacists can treat, which may include influenza, COVID-19, group A streptococcal pharyngitis, and post-exposure prophylaxis for sexually transmitted infections. Pharmacists will be required to complete specific training and education before providing these services.

Additionally, the bill mandates that health insurance carriers provide coverage for the services performed by pharmacists within their lawful scope of practice, effective January 1, 2027. This coverage must be equivalent to what would be provided if the services were performed by a physician, advanced practice nurse, or physician assistant. Insurers cannot require additional supervision, signature, or referral for reimbursement. The legislation aims to improve access to healthcare and ensure that pharmacists are recognized as integral healthcare providers within the health system.